Effect of a novel free radical scavenger, edaravone, on puromycin aminonucleoside induced nephrosis in rats

Pediatric Nephrology : Journal of the International Pediatric Nephrology Association
Tomonosuke SomeyaYuichiro Yamashiro

Abstract

Recent studies indicate that excessive production of oxidants plays a role in the pathogenesis of glomerular injury leading to proteinuria in patients with minimal-change nephrotic syndrome (MCNS). The novel free radical scavenger, edaravone (EDA), which was recently developed in Japan, is currently used in patients with stroke. We studied whether this new agent would be beneficial in patients with MCNS by its antioxidant activity and examined its effect on proteinuria in nephrosis induced by puromycin-aminonucleoside (PAN) in rats. Nineteen Wistar-Kyoto rats injected with PAN were assigned to four groups: group 1, without EDA (n=4); group 2, concomitant EDA injection from 1 day prior to PAN administration (n=5); group 3, concomitant EDA injection from 1 day after PAN administration (n=5); group 4, concomitant EDA injection from 3 days after PAN administration (n=5). Daily urinary excretions of protein and 8-hydroxy-2'-deoxyguanosine (8-OHdG), a new sensitive marker of oxidative DNA damage in vivo, were measured in each group from the 1st to the 30th day after PAN injection. In group 1 proteinuria developed from the 5th day and reached the peak level on the 9th day. In groups 2, 3, and 4 proteinuria did not appear until the 6th...Continue Reading

References

Jan 21, 2009·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Anna IharadaToshimasa Nishiyama
Jul 25, 2012·Free Radical Biology & Medicine·Qiaojing YanJian Yao
Mar 1, 2012·Journal of the American Society of Hypertension : JASH·Li-Juan MinMasatsugu Horiuchi
Jun 30, 2015·Laboratory Investigation; a Journal of Technical Methods and Pathology·Izabella Z A PawluczykPeter S Topham
Nov 5, 2016·Clinical and Experimental Nephrology·Keisuke SugimotoTsukasa Takemura
Sep 13, 2012·Experimental and Therapeutic Medicine·Kiyoshi KikuchiKo-Ichi Kawahara

Citations

Mar 1, 1992·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J R Diamond
Jan 1, 1991·Free Radical Biology & Medicine·M K Shigenaga, B N Ames
Nov 1, 1991·Kidney International·R T FiserB Shirkey
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·C G FragaB N Ames
Apr 1, 1988·Stroke; a Journal of Cerebral Circulation·K AbeK Kogure
Feb 1, 1986·Kidney International·J R DiamondM J Karnovsky
May 1, 1996·Free Radical Research·U MinhazH Nakazawa
Jan 1, 1997·Free Radical Biology & Medicine·S TúriJ Nagy
Oct 23, 1997·The Journal of Biological Chemistry·C J RaatsJ H Berden
Jan 5, 1999·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·J FydrykH Bukowska
Jan 12, 2000·Archives of Disease in Childhood·S KinraB C Kabi
Dec 31, 2002·Journal of the American Society of Nephrology : JASN·Hiroshi KawachiFujio Shimizu
Mar 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·Minoru SatohHirofumi Makino
Sep 5, 2003·The Journal of Pharmacology and Experimental Therapeutics·Hiroshi KonoYoshiro Matsumoto
Sep 24, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Young Ki LeeHirashi Kawachi

Related Concepts

Pathogenic Aspects
Pathogenesis
Nephrotic Syndrome
Phenylmethylpyrazolone
Renal Glomerular Disease
Free Radicals
MCI 186
Proteinuria
Nephrosis
Pyramidone

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.